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The incidence of life-threatening systemic fungal infections has been increasing in recent years, and 
the increasing incidence has been correlated with increasing numbers of immunocompromised 
patients. We developed a two-step PCR assay that specifically amplifies a region of the 18S rRNA gene 
that is highly conserved in Aspergillus fumigatus. This assay allows direct and rapid detection of down 
to 10 fg of Aspergillus fumigatus DNA corresponding to 1 to 5 colony forming unit (CFU) per ml of 
sputum sample of pulmonary tuberculosis patients. The two primer pairs that produced PCR products 
with the highest sensitivity and species specificity were the Aspergillus fumigatus primers AFU7S and 
AFU7AS, which amplified a fragment of 405 bp, followed by AFU5S and AFU5AS, which produced an 
internal fragment of 236 bp. PCR has been shown to be a highly sensitive diagnostic tool for the 
detection of infectious fungi specimens. Our point to the considerable potential clinical value of this 
simple, specific, rapid, and inexpensive PCR assay is for improving the means of early diagnosis of 
systemic aspergillosis tuberculosis patients. 
 





The incidence of life-threatening systemic fungal infec-
tions has been increasing in recent years, and the 
increasing incidence has been correlated with increasing 
numbers of immunocompromised patients (Anaissie et 
al., 1989; Bodey et al., 1992; Beck-Sague, and Jarvis, 
1993; Groll et al., 1996; Denning et al., 1998; Kami et al., 
2000). Patients at the greatest risk are those with 
prolonged periods of pulmonary tuberculosis after inten-
sive immunosuppressive chemotherapy, for example, 
during treatment for acute leukemia or after bone marrow 
transplantation. Particularly on the increase are invasive 
infections with Aspergillus fumigatus, resulting in high 
mortality rates or, if the patient survives, causing high 
levels of morbidity that often limit further antileukemic 
therapies. Antifungal prophylaxis is controversial and is 
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al., 1994; Chandrasekar et al., 1995; Wald et al., 1997; 
Lin et al., 2001). Moreover, amphotericin B is toxic. In 
contrast to other infections, only limited conventional 
diagnostic tools with poor sensitivity and reliability are 
available for early detection of invasive aspergillosis 
(Walsh et al., 1991; Denning et al., 1994; Guiot et al., 
1994; Hughes et al., 2002.) with the systemic infection 
frequently being diagnosed late or confirmed only at 
autopsy (Bodey et al., 1992; Pfaffenbach et al., 1994; 
Chandrasekar et al., 1995; Groll et al., 1996). The PCR 
test commonly used in the initial period of infection during 
pulmonary tuberculosis are often insufficient not only for 
accurate early diagnosis but also for monitoring of the 
subsequent course of invasive aspergillosis (Anaissie et 
al., 1989; Blum et al., 1994; Guiot et al., 1994; Logan et 
al., 1994; Obayashi et al., 1994; Hearn et al., 1995; 
Stynen et al., 1995; Verweij et al., 1995; Walsh et al., 
1995a, b; Kappe et al., 1996; Caillot et al., 1997; Swanink 
et al., 1997; Lewin et al., 1999; Loeffler et al., 2000a; 
Kearns et al., 2001; Palladino et al., 2001). In view of the 






diagnosis of an invasive aspergillosis can be proven con-
clusively only by positive histology or culture results (Bart-
Delabesse et al., 2001). However, establishing cultures 
from blood and bronchoalveolar lavage (BAL) samples is 
often unsuccessful due to the low yields of CFU, and in 
the case of immunocompromised high-risk patients who 
are febrile, pulmonary tuberculosis, neutropenic, throm-
bocytopenic, and often seriously ill, tissue biopsy speci-
mens, in general, are not available.  
Many authors have reported detection of Aspergillus 
nucleic acids by PCR for improved diagnosis of invasive 
aspergillosis. Target sequences, either panfungal riboso-
mal DNA (rDNA) (Einsele et al., 1997; Hebart et al., 
2000; Hendolin et al., 2000; Lass-Florl et al., 2001; 
Loeffler et al., 2000; Loeffler et al., 1998) or Aspergillus-
specific mitochondrial 
DNA (mtDNA) (Bretagne et al., 1998; Costa et al., 
2002; Jones et al., 1998) or rDNA sequences (Buchheidt 
et al., 2002; Buchheidt et al., 2001; Kami et al., 2001; 
Skladny et al., 1999) have been amplified from BAL fluids 
(Skladny et al., 1999; Buchheidt et al., 2002) serum 
(Bretagne et al., 2002; Costa et al.,2002), or whole blood 
(Buchheidt et al.,2002; Hebart et al., 2000; Einsele et al., 
1997; Lass-Florl et al., 2001).  The diagnosis of mycotic 
infections in pulmonary tuberculosis patients by molecu-
lar methods such as Southern blot analysis has been 
performed successfully with lung. More sensitive and 
rapid detection assays have been established by use of 
the PCR method, particularly following the identification 
and sequencing of multicopy gene templates in a range of 
fungi and other organisms. PCR assays for the detection 
of fungal nucleic acids may be the optimal diagnostic 
approach because they are potentially more sensitive 
than current culture-based methods and may be designed 
to encompass the desired range of genera and specimen 
types. Previous studies evaluating PCR-mediated detec-
tion of Aspergillus species showed significantly improved 
sensitivity but involved assays with different methods and 
objectives, partly to optimize culture assays (Burg et al., 
1989; Makimura et al., 1994; Hayden et al., 2001.) and 
partly for typing in epidemiological studies (Aufavre et al., 
1992; Girardin et al., 1994; Birch et al., 1995; Groll et al., 
1996). Therefore, the results of different groups are not 
consistent or comparable. By using PCR primers specific 
for the multicopy 18S rRNA gene, very small amounts 
(down to 1 pg) of genomic DNA from A. fumigatus have 
been detected, the sensitivity being increased to 100 fg 
by (Spreadbury et al., 1993). 
Melchers et al. (1994) first described a PCR assay for 
the detection of DNA from an Aspergillus sp. in immuno-
compromised patients with primers based on the coding 
sequence of the 18S rRNA gene which is highly 
conserved and which is amplified some hundredfold in the 
Aspergillus genome. PCR products were obtained from BAL 
samples of immunocompromised while no amp- licons were 
obtained from immunocompetent individuals. However, 
Yamakami et al. (1996) first described the use of a two-step 
PCR to detect Aspergillus spp. in blood with  increased  spe- 




specificity and sensitivity, but that study was performed 
with only a small number of patients. Einsele et al. (1997) 
described a PCR assay with subsequent Southern blot 
analysis, which allowed the detection of fungal pathogens 
(including Aspergillus spp.) in blood samples.  
In order to achieve an improved, specific, and rapid 
means of detection of Aspergillus fumigatus in clinical 
specimens, we developed a two-step PCR assay for 
sputum samples. Two optimal pairs of oligonucleotide 
primers derived from sequences of the 18S rRNA gene, 
which are specific for A. fumigatus. The assay was 
evaluated for its sensitivity and specificity in vitro and was 




MATERIALS AND METHOD 
 
Clinical samples and isolation 
 
A. fumigatus test strains were isolated from the sputum samples of 
pulmonary tuberculosis patients from the civil hospital of Washim, 
Washim District, Maharashtra state, India. Sputum samples (2 - 4 
ml) were obtained under sterile conditions. The samples were 
inoculated in appropriate sterile Czapek Dox Agar plates at 25°C for 
3 to 4 days. The cell density of the fungal suspensions (conidia) 
was determined microscopically by counting the cell number in a 
Neubauer cell chamber.  
 
 
DNA isolation  
 
DNA was isolated from larger scale (25 ml) cultures. Mycelium were 
separated by filtration and washed three times in cold buffer (20mM 
sodium citrate pH 5.8 in 1 M sorbitol), ground in liquid nitrogen and 
resuspended in lyses buffer (50 mM Tris-HCl (pH 8), 50 mM EDTA, 
3% sodium dodecyl sulfate, and 1% - mercaptoethanol). The 
suspension was then incubated at 65ºC for 1 h. After the cell debris 
had been pelleted, the lysate was extracted once with phenol-
chloroform (1:1) and once with a chloroform-isoamyl alcohol (24:1). 
The DNA was precipitated by the addition of 0.2 volume of 3 M 
potassium acetate and 0.5 volume of isopropanol; after centrifu-
gation, the DNA pellets were washed with 70% ethanol and 
resupended in buffer (10 mMTris-HCl pH-8, 1mM EDTA).  
The purification of fungal DNA was performed by conventional 
extraction (Sambrook et al., 1989). The DNA was precipitated by 
the addition of 0.7 volume of isopropanol, pelleted, and washed 
once with 70% ethanol and air-dried. The DNA concentration was 
assessed by spectrophotometer at 260 and 280 nm.  
 
 
Oligonucleotide primers, primer sequences, and PCR assay  
 
The alignment of the three DNA sequences was performed with the 
program Gene works (Intelligentsias, Inc.) by using standard algori-
thms. Primers were designed to have sequences homologous to 
those of A. fumigatus but not to include the human 18S rRNA gene 
or the 16S rRNA genes of Candida spp. or other pathogenic micro-
organisms. Therefore, selection of the primer sequences was based 
on a close check for sequences with matching homologies in 
current DNA databases (GenBank, release June 1998) with a DNA 
alignment program (Blast). By using a nested, two-step PCR 
technique, 4 different primers (Table 1) were tested, and the 
optimum two pairs (primers AFU5S and AFU5AS and primers 
AFU7S and AFU7AS) were chosen for all subsequent PCR assays 
(Figure 1).  
 














AFU5S AGG GCC AGC GAG TAC ATC ACC TTG 1436-1459 A. fumigatus 
AFU5AS GG G (AG)GT CGT TGC CAA C(CT)C (CT)CC TGA 1648-1771 A. fumigatus 
AFU7S CGG CCC TTA AAT AGC CCG 1296-1313 A. fumigatus 






Figure 1. Locations of primer pairs AFU5S-AFU5AS and AFU7S-
AFU7AS used in the two-step PCR to detect Aspergillus DNA. The 
primers are derived from the 18S rRNA gene of Aspergillus spp. 
The first PCR step (with AFU7S-AFU7AS) results in amplification of 
a 405-bp fragment, and the second step with AFU5S-AFU5AS) 




Reaction and conditions of (PCR)   
 
Per 25 µl PCR mixtures, approximately 50 to 150 ng of total DNA 
was used as the template. The standard PCR mixture contained 
0.5 U of Taq DNA polymerase, 6.25 nmol of the deoxynucleoside 
triphosphates, 10 pmol of primer (first step, primer AFU7S-
AFU7AS; second step, primer AFU5S-AFU5AS). In preliminary 
studies the optimum reaction conditions were established by testing 
different DNA, primer, enzyme, and deoxynucleoside triphosphate 
concentrations as well as a range of cycling conditions. PCR was 
performed in a thermal cycler (Perkin-Elmer Cetus), as follows: for 
the first PCR, 2 min at 94°C and then 35 cycles of 40 s at 94°C, 
1 min at 60°C, and 1 min at 72°C with a terminal step of 5 min at 
72°C and then the mixture was held at 4°C; for the second PCR, 
2 min at 94°C and then 45 cycles of 40 s at 94°C, 1 min at 60°C, 
and 1 min at 72°C, with a terminal step of 5 min at 72°C, and then 
the mixture was held at 4°C. For the second PCR, 10 µl of the first-
round PCR product was used. The PCR products were separated 
by 2% agarose gel electrophoresis, stained with ethidium bromide, 
and visualized with Gel-doc instrument. Control samples included 
all the constituents in the reaction mixture except genomic DNA. As 




RESULT AND DISCUSSION 
 
The alignment of the 18S rRNA genes of A. fumigatus, 
humans, and Candida sp. revealed several regions of 
significant divergence, which were the basis for selection 
of the primers. In order to establish a PCR assay specific 
for several Aspergillus species of clinical importance the 
18S rRNA gene (rDNA) sequence of A. fumigatus 
(GenBank accession no. AB008401) was aligned with the 
human 18S rDNA sequence (GenBank accession no. 
M10098) and the 16S rDNA sequence of C. albicans 
(GenBank accession no. X53497), another ubiquitous 
microorganism of major clinical importance. Four different 
primers, comprising 7 sequences upstream and 
8 sequences downstream from various divergent regions 
of the Aspergillus species gene, which showed the least 
homology with the human, or Candida genes, were 
selected for the evaluation and the optimization of the 
PCR assay.  
The two primer pairs that produced PCR products with 
the highest sensitivity and species specificity were the A. 
fumigatus primers AFU7S and AFU7AS, which amplified 
a fragment of 405 bp, followed by AFU5S and AFU5AS, 
which produced an internal fragment of 236 bp (Figures 2 
and 3). PCR products could be obtained only from DNA 
of cultures of A. fumigatus, whereas the PCRs with the 
other Phoma test strains were negative. By monitoring 
the clinical course of this pulmonary tuberculosis patient, 
in whom a small lung infiltration was detected by chest X 
ray, we could neither prove nor exclude invasive 
aspergillosis. PCR has been shown to be a highly 
sensitive diagnostic tool for the detection of infectious 
fungi in diverse specimens. 
Spradbury et al. (1993) initiated pioneer work in this 
direction after multicopy gene targets, such as the 28S 
rRNA gene, had been identified and sequenced. The first 
PCR assay for the detection of Aspergillus DNA in 
immunocompromised patients described (Melchers et al., 
1994) used primers derived from the multicopy 18S rRNA 
gene, a gene of numerous microorganisms that has now 
been sequenced. More recent reports described PCR 
techniques with primers designed to target conserved 
18S rRNA sequences common to a variety of fungal 
pathogens (Einsele et al. 1997; van Burik et al., 1998). 
However, additional Southern blot analyses with longer 
probes were also necessary to achieve the detection 
sensitivity for the identification of the specific fungal 
species or genera present. Nested PCR assays improved 
the detection sensitivity. In the first description of such a 
two-step PCR for the detection of A. fumigatus in serum 
samples of patients, Yamakami et al. (1996) reported that 
a PCR with two sets of 18S rRNA primers had consi-
derably improved sensitivity compared to that of a PCR 
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Figure 2. Determination of the sensitivity of the two-step PCR 
assay with purified A. fumigatus DNA (50 ng). The Aspergillus 
template DNA was clearly detectable by ethidium bromide 
staining of an agarose gel. Only DNA extracted from 
A. fumigatus (lane 5) was used in a single PCR amplification 
of the 236-bp fragment with the second primer pair. Negative 
reagent control amplification without addition of DNA (lane 1 
and 2) as well as purified DNA from Phoma, DNA resulted in 
no bands (lane 3, 4). The Lambda DNA EcoR1/Hind III was 
used as molecular size marker (lane 9). Diluted sample of 




improved by subsequent Southern blot hybridization. 
These data also highlighted for the first time the use of 
PCR for the detection of Aspergillus DNA in blood 
samples, which can be obtained by a less noninvasive 
procedure that is associated with fewer risks than the 
procedure used to collect BAL specimens, which cannot 
be performed repeatedly with immunocompromised 
patients. 
We also used a two-step PCR procedure with carefully 
selected primers to increase the sensitivity and specificity 
for A. fumigatus detection. The multicopy 18S rRNA gene 
is highly conserved in all species but includes variable 
regions that are conserved among most Aspergillus 
species. On the basis of comparisons with sequences in 
a data bank, we chose oligonucleotides from the variable 
regions that specifically matched only the 18S rRNA gene 
of A. fumigatus to avoid problems arising from co 
amplification of human or bacterial DNA or contamination 
with other fungus-derived DNA. Two pairs of nested 
primers were chosen for use in all subsequent assays. 






A specific two-step PCR assay for the rapid detection of 
the full range of human pathogenic Aspergillus species in 
sputum  samples  was  established,  facilitating  improved  






Figure 3. Determination of the sensitivity of the two-step PCR 
assay with purified A. fumigatus DNA (50 ng). The single 
derived from 10 fg of Aspergillus templet DNA was clearly 
detectable by ethidium bromide staining of agarose gel. As a 
positive control, only DNA extracted from A. fumigatus (10pg) 
was used in a single PCR amplification of 236-bp fragment with 
the second primer pair (lane +) Anegative control amplification 
without addition of DNA lane (-) as well as purified DNA from a 
human cell line (T47D) resulted in no bands. The 123-bp ladder 




early diagnosis and better monitoring of systemic A. 
fumigatus infection in pulmonary tuberculosis patients 
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